Back to resultsRelationship of Metabolic Syndrome and Its Components With Thyroid Cancer
Primary Purpose
Thyroid Cancer
Status
Unknown status
Phase
Locations
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Thyroid Cancer focused on measuring Metabolic Syndrome, fasting plasma glucose
Eligibility Criteria
Inclusion Criteria:
- patients undergone thyroid surgery
- signed the informed consent
Exclusion Criteria:
1.patients with no surgery
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Arm Label
The thyroid cancer group
The thyroid nodule group
Arm Description
The postoperative pathology of thyroid is malignant
The postoperative pathology of thyroid is benign
Outcomes
Primary Outcome Measures
lipids
Secondary Outcome Measures
glucose
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03006289
Brief Title
Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
Official Title
Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
Study Type
Observational
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
October 2017 (Anticipated)
Study Completion Date
November 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Lin Liao
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen for the risk factors that affect the incidence of thyroid cancer.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thyroid Cancer
Keywords
Metabolic Syndrome, fasting plasma glucose
7. Study Design
Enrollment
3000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
The thyroid cancer group
Arm Description
The postoperative pathology of thyroid is malignant
Arm Title
The thyroid nodule group
Arm Description
The postoperative pathology of thyroid is benign
Primary Outcome Measure Information:
Title
lipids
Time Frame
before the thyroid surgery
Secondary Outcome Measure Information:
Title
glucose
Time Frame
before the thyroid surgery
Other Pre-specified Outcome Measures:
Title
blood pressure
Time Frame
before the thyroid surgery
Title
Uric Acid
Time Frame
before the thyroid surgery
Title
sialic acid
Time Frame
before the thyroid surgery
Title
thyroid function
Time Frame
before the thyroid surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
patients undergone thyroid surgery
signed the informed consent
Exclusion Criteria:
1.patients with no surgery
Study Population Description
patients undergone thyroid surgery
Sampling Method
Non-Probability Sample
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lin Liao, MD
Phone
8615168888260
Email
liaolin@medmail.com.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lin Liao, MD
Organizational Affiliation
Qianfoshan Hospital
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
35299970
Citation
Zhao J, Tian Y, Jia Z, Yao J, Liao L, Dong J. Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China. Front Endocrinol (Lausanne). 2022 Mar 1;13:806349. doi: 10.3389/fendo.2022.806349. eCollection 2022.
Results Reference
derived
PubMed Identifier
33585179
Citation
Zhao J, Tian Y, Yao J, Gu H, Zhang R, Wang H, Liao L, Dong J. Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population. Front Oncol. 2021 Jan 28;10:508126. doi: 10.3389/fonc.2020.508126. eCollection 2020.
Results Reference
derived
Learn more about this trial
Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
We'll reach out to this number within 24 hrs